Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Genomics, |
RCV001281016 | SCV001468420 | uncertain significance | Kostmann syndrome | 2021-03-30 | criteria provided, single submitter | clinical testing | HAX1 NM_006118.3 exon 2 p.Arg74His (c.221G>A): This variant has not been reported in the literature but is present in 0.04% (10/24972) of African alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/1-154245979-G-A?dataset=gnomad_r2_1). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Ambry Genetics | RCV004978239 | SCV005596182 | uncertain significance | Inborn genetic diseases | 2024-12-02 | criteria provided, single submitter | clinical testing | The p.R74H variant (also known as c.221G>A), located in coding exon 2 of the HAX1 gene, results from a G to A substitution at nucleotide position 221. The arginine at codon 74 is replaced by histidine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. |